Financials

  • Market Capitalization 28.34 M
  • Employee 17
  • Founded 2007
  • CEO Par Nijhawan
  • Website www.edesabiotech.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000R0LC72
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.95
Rapporto prezzo/fatturato
-235.22

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4382
IGC
IGC Pharma, Inc. Common Stock
0.28 USD0.00%0.00%0.00%+9.29%28.95 M USD
4385
CNTX
Context Therapeutics Inc. - Common Stock
0.31 USD+3.33%-8.82%-11.43%-77.86%28.48 M USD
4396
RNAZ
TransCode Therapeutics, Inc. - Common Stock
1.63 USD-12.37%-7.91%-1.21%-82.86%27.60 M USD
4405
MCRB
Seres Therapeutics, Inc. - Common Stock
2.68 USD-1.11%-6.94%-46.40%-67.44%26.64 M USD

Notizie